Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study

Overview of attention for article published in BMC Cancer, May 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter: 16 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 68 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 17 X posts from 16 X users, with an upper bound of 12,919 followers.

Previous work discovered more tx delays in patients with COVID-19 compared with uninfected peers. https://t.co/v7UKvXMT75 Ours is the first to identify systemic delays/cancellations in cancer tx for a cohort of patients who were ALL diagnosed with #COVI

29 Jul 2022

Reply Repost Favourite

New article: Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study https://t.co/ynQHPgSQIA #coronavirus #COVID19 #2019ncov https://t.co/2VcS6FKvw3

21 May 2021

Reply Repost Favourite

RT @KaerenH: #NCYT Another great find by Kat Hassard. Primerdesign showing us the meaning of versatility. https://t.co/Ukl5WSsApZ

21 May 2021

Reply Repost Favourite

RT @KaerenH: #NCYT Another great find by Kat Hassard. Primerdesign showing us the meaning of versatility.

21 May 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 13 additional X posts.